Search research articles
Contact Us
Filters
Showing results (201-210 of 278) with videos related to
Page
of 28
Sort By:
The Journal of Pathology
|
December 11, 2024
Stress testing deep learning models for prostate cancer detection on biopsies and surgical specimens
Brennan T Flannery, Howard M Sandler, Priti Lal, et al.
The Journal of Urology
|
March 23, 2023
Impact of an Expanded Definition of Family History on Outcomes of Active Surveillance for Prostate Cancer
Adam C Schneider, Thenappan Chandrasekar, Nicholas Bowler, et al.
Urologic Oncology
|
July 7, 2016
Acute and late urinary toxicity following radiation in men with an intact prostate gland or after a radical prostatectomy: A secondary analysis of RTOG 94-08 and 96-01
Raymond H Mak, Daniel Hunt, Jason A Efstathiou, et al.
European Urology
|
November 7, 2021
The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma
Richard Cathomas, Anja Lorch, Harman M Bruins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 3, 2024
Bladder-Preserving Trimodality Treatment for High-Grade T1 Bladder Cancer: Results From Phase II Protocol NRG Oncology/RTOG 0926
Douglas M Dahl, Joseph P Rodgers, William U Shipley, et al.
Clinical Genitourinary Cancer
|
January 1, 2018
Contemporary Patterns of Multidisciplinary Care in Patients With Muscle-invasive Bladder Cancer
Lauren C Harshman, Abhishek Tripathi, Matthew Kaag, et al.
Urologic Oncology
|
October 23, 2017
The prognostic effect of salvage surgery and radiotherapy in patients with recurrent primary urethral carcinoma
Georgios Gakis, Tina Schubert, Todd M Morgan, et al.
European Urology
|
March 21, 2025
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines
Antoine G van der Heijden, Harman Max Bruins, Albert Carrion, et al.
European Urology Oncology
|
July 13, 2023
Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524-A Phase 1/2 Trial of Paclitaxel + Trastuzumab with Daily Radiation or Paclitaxel Alone with Daily Irradiation
Douglas M Dahl, Theodore G Karrison, M Dror Michaelson, et al.
Nature Reviews. Urology
|
September 11, 2021
Refining neoadjuvant therapy clinical trial design for muscle-invasive bladder cancer before cystectomy: a joint US Food and Drug Administration and Bladder Cancer Advocacy Network workshop
Elaine Chang, Andrea B Apolo, Rick Bangs, et al.
Page
of 28
Search research articles
Search
Showing results (201-210 of 278) with videos related to
Sort By:
Page
of 28
The Journal of Pathology
|
December 11, 2024
Stress testing deep learning models for prostate cancer detection on biopsies and surgical specimens
Brennan T Flannery, Howard M Sandler, Priti Lal, et al.
The Journal of Urology
|
March 23, 2023
Impact of an Expanded Definition of Family History on Outcomes of Active Surveillance for Prostate Cancer
Adam C Schneider, Thenappan Chandrasekar, Nicholas Bowler, et al.
Urologic Oncology
|
July 7, 2016
Acute and late urinary toxicity following radiation in men with an intact prostate gland or after a radical prostatectomy: A secondary analysis of RTOG 94-08 and 96-01
Raymond H Mak, Daniel Hunt, Jason A Efstathiou, et al.
European Urology
|
November 7, 2021
The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma
Richard Cathomas, Anja Lorch, Harman M Bruins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 3, 2024
Bladder-Preserving Trimodality Treatment for High-Grade T1 Bladder Cancer: Results From Phase II Protocol NRG Oncology/RTOG 0926
Douglas M Dahl, Joseph P Rodgers, William U Shipley, et al.
Clinical Genitourinary Cancer
|
January 1, 2018
Contemporary Patterns of Multidisciplinary Care in Patients With Muscle-invasive Bladder Cancer
Lauren C Harshman, Abhishek Tripathi, Matthew Kaag, et al.
Urologic Oncology
|
October 23, 2017
The prognostic effect of salvage surgery and radiotherapy in patients with recurrent primary urethral carcinoma
Georgios Gakis, Tina Schubert, Todd M Morgan, et al.
European Urology
|
March 21, 2025
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines
Antoine G van der Heijden, Harman Max Bruins, Albert Carrion, et al.
European Urology Oncology
|
July 13, 2023
Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524-A Phase 1/2 Trial of Paclitaxel + Trastuzumab with Daily Radiation or Paclitaxel Alone with Daily Irradiation
Douglas M Dahl, Theodore G Karrison, M Dror Michaelson, et al.
Nature Reviews. Urology
|
September 11, 2021
Refining neoadjuvant therapy clinical trial design for muscle-invasive bladder cancer before cystectomy: a joint US Food and Drug Administration and Bladder Cancer Advocacy Network workshop
Elaine Chang, Andrea B Apolo, Rick Bangs, et al.
Page
of 28